PMH31 Cost-Effectiveness of Long-Acting Olanzapine Versus Long-Acting Risperidone in Patients with Schizophrenia in Spain
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.331
https://www.valueinhealthjournal.com/article/S1098-3015(11)01893-6/fulltext
Section Title :
Mental Health
Section Order :
312
First Page :
A292
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01893-6&doi=10.1016/j.jval.2011.08.331